key: cord-0959432-xopn0vhq authors: Meng, Long; Huang, Jing; Qiu, Feng; Sun, Shusen title: Roles of the Chinese clinical pharmacist during the COVID‐19 pandemic date: 2020-06-04 journal: J Am Coll Clin Pharm DOI: 10.1002/jac5.1274 sha: afac1b87165b4f22e1ddc26bd5761706c4450720 doc_id: 959432 cord_uid: xopn0vhq nan system has been established, and the clinical pharmacist has become an essential member of the multi-disciplinary team providing pharmaceutical care to patients. Chinese clinical pharmacists provide education, medication review, adverse drug reaction (ADR) monitoring services for patients, and sometimes make medication and laboratory recommendations or provide medication consultation for other healthcare providers. 2 The respiratory illness due to SARS-CoV-2, termed COVID-19, is now a worldwide pandemic. Chinese clinical pharmacists actively provide a variety of pharmacy services during the coronavirus pandemic, demonstrating the impact of the clinical pharmacist system. 3, 4 In this editorial, we describe the roles of the Chinese clinical pharmacists during the COVID-19 pandemic to share with the international pharmacy community. Table 1 . [6] [7] [8] Clinical pharmacists pay particular attention to the special patient populations-elderly, 9 pregnant, children, and patients with comorbidities. 10, 11 Clinical pharmacists also closely monitor drugs/drug classes with more safety concerns, such as lopinavir/ritonavir, 12 ribavirin, 13 interferon, 14 tocilizumab, 15 glucocorticoids, 16 and immunomodulatory drugs. 17 An evaluation of clinical pharmacist service on a neurology care unit The impact of the clinical pharmacistled interventions in China: A systematic review and Meta-Analysis Providing pharmacy services during the coronavirus pandemic Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China Diagnosis and Treatment Guidelines for the New Coronavirus Infected Pneumonia (seventh update). China Discussion on clinical pharmaceutical service model in prevention and treatment of corona virus disease 2019 Comprehensive Pharmaceutical Care for Novel Coronavirus Pneumonia Pharmaceutical Care Strategies of Clinical Pharmacists During the Prevention and Control of the Coronavirus Disease Pharmaceutical Care of Elderly Patients with the Coronavirus Disease Study on the strategy and application of anticoagulant pharmaceutical care during Coronavirus Disease Pharmaceutical Care for Cancer Patients Receiving Antitumor Treatment during the Outbreak of Corona Virus Disease Pharmacological recommendations on the off-label use of Lopinavir/ritonavir for treatment of coronavirus disease 2019 Application, evaluation and pharmaceutical care of ribavirin in the treatment of viral diseases Rational Administration and Pharmaceutical Care of Interferon Alpha Nebulization Therapy in Corona Virus Disease Pharmacological recommendations on tocilizumab for the treatment of COVID-19 Pharmaceutical Care of Glucocorticoid in Corona Virus Disease Rational Use and Pharmaceutical Care of ThymosinImmunomodulators for Novel Coronavirus Pneumonia. Herald of Medicine Risk signals mining of ribavirin and interferon-alpha based on the US FDA Adverse Event Reporting System database Detection and Analysis of the Safety Signals of Lopinavir/Ritonavir Based on FDA Adverse Event Database Practice and discussion of outpatient pharmaceutical care based on medical network model during 2019 novel coronavirus disease (COVID-19) Strategy of pharmaceutical care services for clinical Chinese pharmacists in coronavirus disease 2019 (COVID-19) Fighting against COVID-19: Innovative strategies for clinical pharmacists Construction of Pharmaceutical Care System for Public Health Emergencies Based on the Pharmaceutical Administration in Wuhan Fangcang Hospitals